Simlatus-Satel Group-Proscere Bioscience Announces European CBD Contract Negotiations

San Francisco, California, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC Pink: SIML) (“Simlatus” or the “Company”), the company announces that its CBD division, Proscere Bioscience, is finalizing negotiations with a Switzerland based company to be granted exclusive rights in Europe to distribute the cold-water CBD extraction products.

Chairman and CEO Richard Hylen stated, “I had recent meetings with the Switzerland based company in Los Angeles and look forward to disclosing the deal in the very near future. Negotiating points include exclusive rights for Europe and a positive revenue stream for our company. Switzerland is more advanced and ahead of the CBD market as compared to the United States, in both commercial and recreational applications, especially in the medical pharmaceutical markets. Our cold-water extraction technology provides the process of removing THC laden trichomes from plant material by washing the material in cold water. Our technology provides an advanced method to agitate the leaf and cause the trichomes to separate from the plant material to create the THC laden water solution which will be filtered through a series of our micron screens. Once filtered, the final product is pure and can be processed. Cold-water extraction is a non-volatile solvent form which makes the resin brittle so it can be easily separated. This process is extremely clean and creates a pure, clean product, high in THC and extremely tasty with no chemical residue.”

Richard Hylen further stated, “These are exciting times for this company and our shareholders. Our internet industry division, Satel Group, has recently closed service contracts in metropolitan San Francisco with a 55 story building and a 40 story building. This adds another 146 luxury condominiums and 392 units for DirecTV and Internet services including its planned value-added internet service. We are on track with our growth plan for $12M in revenue.”  

Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.